Stock Events

Stock Events

Oramed Pharmaceuticals (ORMP) Q4 2024 Earnings

7NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.48

-0.25

-0.01

0.22

Details

Expected EPS

0.005

Actual EPS

-0.48

Surprise EPS

-0.49

Surprise Percent

+9,700%

Description

Oramed Pharmaceuticals (ORMP) has reported earnings of -0.48 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.